Latest

5-MeO-DMT

·May 8, 2024·5 min read

Psychedelics Activate Serotonin to Produce Antidepressant Effect

A new study advanced our understanding of how psychedelic drugs activate serotonin receptors to offer potential treatments for neuropsychiatric disorders. The identifies the interaction of psychedelics like LSD and psilocybin with the serotonin receptor 5-HT1A, which is pivotal in their therapeutic effects.

Featured Neuroscience

·October 24, 2022·4 min read

How Psychedelics Light Up Brain’s Neuropathways

Study reveals the basic neurobiology of how psychedelics work at the chemical, molecular, neural, and network levels within the brain.

Featured Neuroscience Psychology

·March 18, 2019·3 min read

Fast-acting psychedelic associated with improvements in depression/anxiety

5-MeO-DMT, a fast-acting synthetic psychedelic, shows promise for treating depression and anxiety. 80% of test subjects reported improvements in symptoms associated with depression and anxiety after taking the drug.

Featured Neuroscience Open Neuroscience Articles

·October 9, 2017·3 min read

Human Minibrains Reveal Effects of Psychedelic Substance

A new study reveals psychedelic substances may have a neuroprotective role when it comes to inflammation. Researchers also report psychedelics can alter signaling pathways associated with neuroplasticity.